Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PCSK6 antisense RNA 1 (PCSK6-AS1) is a long non-coding RNA transcribed from a bidirectional promoter in the PCSK6 gene locus. It spans intronic regions and is alternatively spliced. PCSK6-AS1 and related antisense RNAs may regulate PCSK6 expression and contribute to fine-tuning tissue-specific gene expression, especially in the nervous system. The locus is functionally important for handedness and has potential links to neurodevelopmental disorders; however, the biological activity and disease relevance of PCSK6-AS1 itself are not fully characterized, and it is not considered a canonical therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PCSK6 antisense RNA 1 (PCSK6-AS1).